Literature DB >> 11350905

Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: a study of lymphatic mapping.

Y Miyake1, H Yamamoto, Y Fujiwara, M Ohue, Y Sugita, N Tomita, M Sekimoto, N Matsuura, H Shiozaki, M Monden.   

Abstract

To provide a detailed assessment of micrometastases of colorectal cancer by anatomical mapping of regional lymph nodes (LNs), we analyzed 237 LNs from 11 patients with colorectal cancer by reverse transcription-PCR (RT-PCR) using carcinoembryonic antigen and cytokeratin 20 as genetic markers. All dissected LNs were mapped anatomically and subjected to detection assays for micrometastases. Immunohistochemical analysis was also performed using anti-pancytokeratin antibody AE1/AE3 to confirm the existence of occult cancer cells. By histological analysis, 20 of 237 LNs contained metastatic cells, and they were all positive by both immunohistochemistry and RT-PCR. Of the 217 histologically negative LNs, 14 (6.5%) harbored micrometastases by immunohistochemistry, and 57 (26.2%) were positive for at least one of the two genetic markers. Lymphatic mappings of all patients showed that micrometastases were distributed not only at the pericolic LNs but often at distant LNS: Clinical follow-up study showed that two patients developed recurrence within 1 year after surgery, and both of them had RT-PCR-positive micrometastases in not less than 70% of LNs examined. Moreover, both patients had frequent micrometastases at distant LNs, i.e., those around the root or along the inferior mesenteric artery, when compared with patients with no recurrence. Our findings suggest that genetic diagnosis using the RT-PCR method may be clinically useful along with conventional pathological diagnosis, especially when micrometastases spread to distant LNS:

Entities:  

Mesh:

Year:  2001        PMID: 11350905

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

1.  Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3.

Authors:  Zhi-Wei Zhou; Nick Rieger; Andrew Ruszkiewicz; Guo-Qiang Wang; De-Sen Wan
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 2.  Detection and clinical implications of minimal residual disease in gastro-intestinal cancer.

Authors:  Fabian Wolfrum; Ilka Vogel; Fred Fändrich; Holger Kalthoff
Journal:  Langenbecks Arch Surg       Date:  2005-07-01       Impact factor: 3.445

3.  IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers.

Authors:  Tao Fu; Emmanouil P Pappou; Angela A Guzzetta; Marilia de Freitas Calmon; Lifeng Sun; Alexander Herrera; Fan Li; Christopher L Wolfgang; Stephen B Baylin; Christine A Iacobuzio-Donahue; Weidong Tong; Nita Ahuja
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

4.  Detection of disseminated lung cancer cells in regional lymph nodes by assay of CK19 reverse transcriptase polymerase chain reaction and its clinical significance.

Authors:  Ming Jian Ge; Qing Chen Wu; Mei Wang; Yu Hong Zhang; Liang Bin Li
Journal:  J Cancer Res Clin Oncol       Date:  2005-07-27       Impact factor: 4.553

5.  Tumor micrometastases in mesorectal lymph nodes and their clinical significance in patients with rectal caner.

Authors:  Yang-Chun Zheng; Yu-Ying Tang; Zong-Guang Zhou; Li Li; Tian-Cai Wang; Yi-Ling Deng; Dai-Yun Chen; Wei-Ping Liu
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

6.  Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Rodrigo Oliva Perez; Angelita Habr-Gama; Sidney Tomyo Nishida Arazawa; Viviane Rawet; Sheila Aparecida Coelho Siqueira; Desidério Roberto Kiss; Joaquim José Gama-Rodrigues
Journal:  Int J Colorectal Dis       Date:  2005-03-10       Impact factor: 2.571

7.  Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay.

Authors:  Erkki Lotspeich; Markus Schoene; Heinz Gerngross; Roland Schmidt; Reinhard Steinmann; Marco Ramadani; Susanne Gansauge
Journal:  Langenbecks Arch Surg       Date:  2007-04-25       Impact factor: 3.445

8.  Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?

Authors:  Michael Conzelmann; Ulrich Linnemann; Martin R Berger
Journal:  Int J Colorectal Dis       Date:  2004-09-30       Impact factor: 2.571

9.  Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations.

Authors:  Ulrich Linnemann; Christoph C Schimanski; Christoph Gebhardt; Martin R Berger
Journal:  Int J Colorectal Dis       Date:  2003-11-21       Impact factor: 2.571

10.  CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients.

Authors:  J Harder; V Engelstaedter; H Usadel; S Lassmann; M Werner; P Baier; F Otto; M Varbanova; E Schaeffner; M Olschewski; H E Blum; O G Opitz
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.